Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Betamipron offers nephrotoxicity protection

June 14, 1996

XR-9051: MDR-reversing agent

June 14, 1996

Fujisawa reveals FR-177391, agent for cachexia in cancer patients

June 14, 1996

PN 27.1 compassionate use trial broadened

June 14, 1996

ZK-138723: Schering AG's aromatase inhibitor

June 14, 1996

RPR's Taxotere available in the U.S.

June 14, 1996

Navelbine on Canadian market

June 14, 1996

ISIS-5132/CGP-69846A efficacy reported in Nature Medicine

June 7, 1996

Indena claims colchicine derivatives

June 7, 1996

Manufacturing agreement for Neoprobe's RIGS/ACT activated cell therapy

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...